Cost‐effectiveness of guideline‐based care provision for patients with diabetes‐related foot ulcers: A modelled analysis using discrete event simulation
Authors' conclusion
Higher proportions of patients receiving guideline-based care are less costly and improve patient outcomes. Strategies to increase the proportion of patients receiving guideline-based care are warranted.
Study context
- Population
- Patients with DFU, Australian healthcare perspective
- Comparison
- Higher rates of guideline-based care vs current practice
- Outcome
- Incremental cost-effectiveness ratios (costs and QALYs) vs willingness-to-pay of AUD 28,000 per QALY
- Follow-up
- 3-year time horizon
Methodological detailsmodelled analysis, 3-year time horizon, Australian healthcare perspective, probabilistic sensitivity analyses
- Modelled analysis
- 3-year time horizon
- Australian healthcare perspective
- Probabilistic sensitivity analyses
Main finding
As reported in the abstract
3 years
Cost savings vs current practice
between AUD 0.28 and 1.84 million
Additional quality-adjusted life-years (QALYs) per 1000 patients vs current practice
11-56
Further findings
Probabilistic sensitivity analyses
- Finding robust to parameter uncertainty
Original publication
Cost‐effectiveness of guideline‐based care provision for patients with diabetes‐related foot ulcers: A modelled analysis using discrete event simulation. Diabet Med. Published 30 September 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →